eagle-i University of Hawaii at ManoaUniversity of Hawaii at Manoa
See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

Treatment of patients with newly diagnosed standard risk B-precursor acute lymphoblastic leukemia (ALL)

eagle-i ID


Resource Type

  1. Clinical trial


  1. ClinicalTrials.gov url
  2. Intervention
    Antineoplastic combined chemotherapy
  3. Resource Description
    This partially randomized phase III clinical trial is studying different combinations of risk-adapted chemotherapy regimens and their side effects and comparing how well they work in treating younger patients with newly diagnosed standard-risk acute lymphoblastic leukemia.
  4. Contact
    Berenberg, Jeffrey
  5. PI
    Wilkinson, Robert, M.D.
  6. Topic
    precursor B lymphoblastic lymphoma/leukemia
  7. Study Population
    Children 1 to 9 years newly diagnosed with B-precursor acute lymphoblastic leukemia (ALL), and meeting other therapy-related criteria.
  8. Phase
    Phase 3 clinical trial
  9. Performed by
    Clinical Protocol & Data Management Shared Resource
Provenance Metadata About This Resource Record
Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016